Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s344, 2024. DOI: 10.25251/skin.8.supp.344. Disponível em: https://skin.dermsquared.com/skin/article/view/2350. Acesso em: 30 apr. 2026.